392 - Case Report on Early Treatment of Dentinogenesis Imperfecta

Saturday, May 27, 2023

10:40 AM – 10:55 AM

Location: Exhibit Hall

Has Audio

Presenting Author(s)

ML

Mariya Lelikova, DDS

Resident
Jamaica Hospital Medical Center, New York, United States

Co-Author(s)

KC

Kelly Cervellione, MA, MPHIL

Jamaica Hospital Medical Center
JW

Jeannine G. Weiss, DDS FADSA FAAHD ABPD NDBA ABSCD

Faculty
Jamaica Hospital Medical Center
Jamaica, New York, United States
SC

Samantha Calderon, DDS (she/her/hers)

Pediatric Dental Resident
Jamaica Hospital Medical Center
Jamaica Hospital Medical Center
Oceanside, New York, United States

Program Director(s)

JW

Jeannine G. Weiss, DDS FADSA FAAHD ABPD NDBA ABSCD

Faculty
Jamaica Hospital Medical Center
Jamaica, New York, United States

Dentinogenesis imperfecta type 2 (DI2) is an autosomal dominant genetic condition characterized by abnormal dentin formation. Distinctive features include variable blue-gray to yellow-brown discoloration of the teeth, enamel fracturing, bulbous crowns, cervical constriction and thin roots. Two major concerns of DI2 are excessive wear and loss of vertical dimension of occlusion. Early diagnosis and treatment are essential. Treatment recommendations for dentinogenesis imperfecta should be tailored depending on severity of each case due to generalized guidelines. We describe the case of a 2.5-year-old male who presented with blue-gray discoloration of the teeth. Upon inquiry, the family confirmed that the patient's younger brother and father had signs consistent with the DI2. Since the patient has minimal occlusal wear, there are several treatment algorithms to be considered. The potential pathways for prevention and treatment of oral manifestations of the DI2 population in general and in our patient are discussed in this report.